trial · primary record
Chimeric Antigen Receptor (CAR) Therapy Infusion
Neuroblastoma (NBL)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2032-12-31 |
| Primary endpoint | Incidence and severity of adverse events |
| Registry ID | NCT07897968 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:58.338Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897968
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.